185 related articles for article (PubMed ID: 30005700)
1. Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways.
Gerhard GS; Malenica I; Llaci L; Chu X; Petrick AT; Still CD; DiStefano JK
Clin Epigenetics; 2018 Jul; 10(1):93. PubMed ID: 30005700
[TBL] [Abstract][Full Text] [Related]
2. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
Zhang RN; Pan Q; Zheng RD; Mi YQ; Shen F; Zhou D; Chen GY; Zhu CY; Fan JG
Int J Mol Med; 2018 Jul; 42(1):443-452. PubMed ID: 29568887
[TBL] [Abstract][Full Text] [Related]
4. Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH).
Wu J; Zhang R; Shen F; Yang R; Zhou D; Cao H; Chen G; Pan Q; Fan J
Med Sci Monit; 2018 Oct; 24():6946-6967. PubMed ID: 30270343
[TBL] [Abstract][Full Text] [Related]
5. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.
Hotta K; Kitamoto A; Kitamoto T; Ogawa Y; Honda Y; Kessoku T; Yoneda M; Imajo K; Tomeno W; Saito S; Nakajima A
Sci Rep; 2018 Sep; 8(1):13567. PubMed ID: 30206277
[TBL] [Abstract][Full Text] [Related]
7. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation in Nonalcoholic Fatty Liver Disease.
Hyun J; Jung Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
[TBL] [Abstract][Full Text] [Related]
9. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
[TBL] [Abstract][Full Text] [Related]
10. Liver DNA methylation of FADS2 associates with FADS2 genotype.
Walle P; Männistö V; de Mello VD; Vaittinen M; Perfilyev A; Hanhineva K; Ling C; Pihlajamäki J
Clin Epigenetics; 2019 Jan; 11(1):10. PubMed ID: 30654845
[TBL] [Abstract][Full Text] [Related]
11. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
12. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
Wegermann K; Henao R; Diehl AM; Murphy SK; Abdelmalek MF; Moylan CA
PLoS One; 2018; 13(9):e0204308. PubMed ID: 30265706
[TBL] [Abstract][Full Text] [Related]
13. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
14. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
Hardy T; Zeybel M; Day CP; Dipper C; Masson S; McPherson S; Henderson E; Tiniakos D; White S; French J; Mann DA; Anstee QM; Mann J
Gut; 2017 Jul; 66(7):1321-1328. PubMed ID: 27002005
[TBL] [Abstract][Full Text] [Related]
15. NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition.
Mwinyi J; Boström AE; Pisanu C; Murphy SK; Erhart W; Schafmayer C; Hampe J; Moylan C; Schiöth HB
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Mar; 1862(3):314-323. PubMed ID: 27993651
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in non-alcoholic fatty liver disease.
Lee J; Kim Y; Friso S; Choi SW
Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
18. Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis.
Zhang G; Hou Y
World J Surg Oncol; 2022 Nov; 20(1):364. PubMed ID: 36397165
[TBL] [Abstract][Full Text] [Related]
19. Gene and transposable element methylation in great tit (Parus major) brain and blood.
Derks MF; Schachtschneider KM; Madsen O; Schijlen E; Verhoeven KJ; van Oers K
BMC Genomics; 2016 May; 17():332. PubMed ID: 27146629
[TBL] [Abstract][Full Text] [Related]
20. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
